← All trials
NCT04771442
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2022
- Primary completion
- Aug 31, 2022
- Completion date
- Aug 31, 2023
- First posted
- Feb 25, 2021
- Last posted
- Nov 1, 2021
- Enrollment
- 23
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hospital of South West JutlandLead sponsor
- University of Southern DenmarkCollaborator
- Hospital of South West JutlandOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.